已收盘 12-17 16:00:00 美东时间
0.000
0.00%
Evoke Pharma surges after QOL Medical announces $11 cash acquisition, a 140% premium, expected to close by the end of 2025.
11-04 23:20
U.S. stocks traded lower this morning, with the Dow Jones index falling more th...
11-04 22:53
(来源:一棵大松树) 携手默沙东深耕TROP2ADC全球布局,具有BIC潜力 芦康沙妥珠单抗(SKB264)是公司自主研发的一款靶向...
08-06 15:27
-Data Span Multiple Types of Lung Cancer and Lines of Therapy-Gilead Sciences, Inc. (NASDAQ:GILD) will present new data from the company's broad lung cancer clinical development program during the IASLC 2024 World
2024-09-05 20:12